Search results
Results from the WOW.Com Content Network
Here's what some studies show, along with how mental health experts advise their patients on cannabis use. ... and behavioral health at the Ohio State University Wexner Medical Center, tells Yahoo ...
Cannabis use disorder (CUD), also known as cannabis addiction or marijuana addiction, is a psychiatric disorder defined in the fifth revision of the Diagnostic and Statistical Manual of Mental Disorders and ICD-10 as the continued use of cannabis despite clinically significant impairment.
The institute has conducted an in-depth study of addiction according to its biological, behavioral and social components. It has also supported many treatments such as nicotine patches and gums, and performed research into AIDS and other drug-related diseases. Its monopoly on the supply of research-grade marijuana has proved controversial.
As marijuana use reaches record highs, an experimental drug may help against cannabis use disorder, scientists say. Skip to main content. 24/7 Help. For premium support please call: 800-290-4726 ...
Story at a glance Use of higher-potency cannabis products is associated with increased risks of addiction and psychosis, according to new research. ... have marijuana use disorder, Centers for ...
Medical marijuana researchers typically prefer to use high-potency marijuana, but NIDA's National Advisory Council on Drug Abuse has been reluctant to provide cannabis with high THC levels, citing safety concerns: [26] Most clinical studies have been conducted using cannabis cigarettes with a potency of 2-4% THC.
A 2012 study conducted by the National Center on Addiction and Substance Abuse at Columbia University concluded that the U.S. treatment system is in need of a “significant overhaul” and questioned whether the country’s “low levels of care that addiction patients usually do receive constitutes a form of medical malpractice.”
Among the most promising studies is a 2022 Nature publication reporting that people with moderate to severe anxiety experienced a 60% to 70% reduction in symptoms after four weeks of treatment ...